Research impact map
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jínek, Krzysztof Chylinski, Ines Fonfara, M. Hauer, Jennifer A. Doudna, Emmanuelle Charpentier
- Published
- Science, 2012
- DOI
- 10.1126/science.1225829
- Affiliations
- Howard Hughes Medical Institute; University of California, Berkeley; University of Vienna; Max Perutz Labs; Umeå Centre for Microbial Research; Umeå University; Lawrence Berkeley National Laboratory
- Literature search
- 2 Nov 2026, from OpenAlex, Semantic Scholar, Europe PMC
A. Executive scientific assessment
Abstract
Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems provide bacteria and archaea with adaptive immunity against viruses and plasmids by using CRISPR RNAs (crRNAs) to guide the silencing of invading nucleic acids. We show here that in a subset of these systems, the mature crRNA that is base-paired to trans-activating crRNA (tracrRNA) forms a two-RNA structure that directs the CRISPR-associated protein Cas9 to introduce double-stranded (ds) breaks in target DNA. At sites complementary to the crRNA-guide sequence, the Cas9 HNH nuclease domain cleaves the complementary strand, whereas the Cas9 RuvC-like domain cleaves the noncomplementary strand. The dual-tracrRNA:crRNA, when engineered as a single RNA chimera, also directs sequence-specific Cas9 dsDNA cleavage. Our study reveals a family of endonucleases that use dual-RNAs for site-specific DNA cleavage and highlights the potential to exploit the system for RNA-programmable genome editing.
The AI assessment, research themes and proposals are not available for this map. The verified citation data below are complete.
B. Dynamic citation network
Arrows point from each paper to the work it builds on, labelled with the relationship read from its citing sentence. Grey dotted arrows mean the paper cites the original but its citing sentence was not available, so no stronger claim is made. Drag to pan, scroll to zoom, click a paper for details.
C. Chronological research timeline
Year → research group → publication → finding or relationship → influence within this map. New group marks a group's first paper here.
1989 1 paper
-
Foundation
Molecular Cloning: A Laboratory Manual
Joseph Sambrook · UCLA - Biblioteca de Ciencias de la Salud
Cited by the original133,587 citations overall
2005 1 paper
-
Foundation
Massachusetts Institute of Technology, US
Benjamin P. Lewis · Cell
Cited by the original11,855 citations overall
2007 3 papers
-
Foundation
Université Laval, CA
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Rodolphe Barrangou · Science
Cited by the original6,306 citations overall
-
Foundation
Université Laval, CA
Phage Response to CRISPR-Encoded Resistance in Streptococcus thermophilus
Hélène Deveau · Journal of Bacteriology
Cited by the original1,213 citations overall
-
Foundation
Hôtel-Dieu de Québec, CA
Argonaute proteins: key players in RNA silencing
György Hutvágner · Nature Reviews Molecular Cell Biology
Cited by the original1,362 citations overall
2008 1 paper
-
Foundation
National Institutes of Health, US
Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Stan J. J. Brouns · Science
Cited by the original2,593 citations overall
2009 2 papers
-
Foundation
University of Alicante, ES
Short motif sequences determine the targets of the prokaryotic CRISPR defence system
Francisco J. M. Mojica · Microbiology
Cited by the original1,518 citations overall
-
Foundation
Université Paris-Sud, FR
VARNA: Interactive drawing and editing of the RNA secondary structure
Kévin Darty · Bioinformatics
Cited by the original1,360 citations overall
2010 4 papers
-
Foundation
University of Minnesota, US
Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
Michelle L. Christian · Genetics
Cited by the original2,030 citations overall
-
Foundation
Sangamo BioSciences (United States), US
Genome editing with engineered zinc finger nucleases
Fyodor D. Urnov · Nature Reviews Genetics
Cited by the original2,285 citations overall
-
Foundation
Université Laval, CA
The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Josiane E. Garneau · Nature
Cited by the original2,336 citations overall
-
Foundation
Sangamo BioSciences (United States), US
A TALE nuclease architecture for efficient genome editing
Jeffrey C. Miller · Nature Biotechnology
Cited by the original2,098 citations overall
2011 2 papers
-
Foundation
University of Vienna, AT
Original teamCRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
Elitza M. Deltcheva · Nature
Cited by the original2,563 citations overall
-
Foundation
National Institutes of Health, US
Original teamEvolution and classification of the CRISPR–Cas systems
Kira S. Makarova · Nature Reviews Microbiology
Cited by the original2,512 citations overall
2012 2 papers · original article
-
Foundation
Howard Hughes Medical Institute, US
Original teamRNA-guided genetic silencing systems in bacteria and archaea
Blake Wiedenheft · Nature
Cited by the original1,852 citations overall
-
Original article
Howard Hughes Medical Institute, US
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jínek · Science
17,118 citations overall
2013 16 papers
-
Le Cong
Broad Institute, US
New groupMultiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong · Science
Cites (sentence not available)15,342 citations overall ; cited by 34 later papers in this map
-
Prashant Mali
Harvard University, US
New groupRNA-Guided Human Genome Engineering via Cas9
Prashant Mali · Science
Cites (sentence not available)9,213 citations overall ; cited by 30 later papers in this map
-
J-R Joanna Yeh
Harvard University, US
New groupEfficient genome editing in zebrafish using a CRISPR-Cas system
Woong Y. Hwang · Nature Biotechnology
Cites (sentence not available)2,937 citations overall ; cited by 13 later papers in this map
-
David Bikard
Rockefeller University, US
New groupRNA-guided editing of bacterial genomes using CRISPR-Cas systems
Wenyan Jiang · Nature Biotechnology
Cites (sentence not available)2,430 citations overall ; cited by 15 later papers in this map
-
Jennifer A. Doudna
Howard Hughes Medical Institute, US
Original teamRNA-programmed genome editing in human cells
Martin Jínek · eLife
Cites (sentence not available)2,098 citations overall ; cited by 16 later papers in this map
-
Lei S. Qi
QB3, US
New group Original teamRepurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Lei S. Qi · Cell
Cites (sentence not available)5,014 citations overall ; cited by 12 later papers in this map
-
Rudolf Jaenisch
Whitehead Institute for Biomedical Research, US
New groupHaoyi Wang · Cell
Cites (sentence not available)3,495 citations overall ; cited by 14 later papers in this map
-
Carlos F. Barbas
Scripps Research Institute, US
New groupZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Thomas Gaj · Trends in biotechnology
Cites (sentence not available)3,818 citations overall ; cited by 1 later paper in this map
-
J. Keith Joung
Harvard University, US
New groupHigh-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Yanfang Fu · Nature Biotechnology
“The Cas9 nuclease from S. pyogenes (hereafter simply Cas9) can be guided via simple base pair complementarity between the first 20 nucleotides of an engineered gRNA and a target genomic DNA sequence of interest that lies next to a protospac...”
Cites as background3,294 citations overall ; cited by 17 later papers in this map
-
Jonathan S. Weissman
QB3, US
New group Original teamCRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Luke A. Gilbert · Cell
Cites (sentence not available)3,697 citations overall ; cited by 9 later papers in this map
-
Feng Zhang
Broad Institute, US
New groupDNA targeting specificity of RNA-guided Cas9 nucleases
Patrick D. Hsu · Nature Biotechnology
Cites (sentence not available)4,741 citations overall ; cited by 22 later papers in this map
-
Feng Zhang
Broad Institute, US
Cites (sentence not available)3,300 citations overall ; cited by 13 later papers in this map
-
Feng Zhang
Broad Institute, US
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran · Nature Protocols
Cites (sentence not available)11,134 citations overall ; cited by 4 later papers in this map
-
Lei S. Qi
QB3, US
Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System
Baohui Chen · Cell
Cites (sentence not available)1,967 citations overall ; cited by 3 later papers in this map
-
Feng Zhang
Broad Institute, US
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem · Science
Cites (sentence not available)5,235 citations overall ; cited by 9 later papers in this map
-
David M. Sabatini
Broad Institute, US
New groupGenetic Screens in Human Cells Using the CRISPR-Cas9 System
Wang Tim · Science
Cites (sentence not available)2,855 citations overall ; cited by 9 later papers in this map
2014 9 papers
-
Sangsu Bae
Seoul National University, KR
New groupSangsu Bae · Bioinformatics
Cites (sentence not available)2,340 citations overall ; cited by 4 later papers in this map
-
Jeffry D. Sander
Harvard University, US
New groupImproving CRISPR-Cas nuclease specificity using truncated guide RNAs
Yanfang Fu · Nature Biotechnology
Cites (sentence not available)1,994 citations overall ; cited by 10 later papers in this map
-
Feng Zhang
Broad Institute, US
Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
Hiroshi Nishimasu · Cell
Cites (sentence not available)2,307 citations overall ; cited by 13 later papers in this map
-
J. Keith Joung
Harvard University, US
CRISPR-Cas systems for editing, regulating and targeting genomes
Jeffry D. Sander · Nature Biotechnology
Cites (sentence not available)3,153 citations overall ; cited by 9 later papers in this map
-
Feng Zhang
Broad Institute, US
Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu · Cell
Cites (sentence not available)5,758 citations overall ; cited by 8 later papers in this map
-
Phillip A. Sharp
Koch Institute for Integrative Cancer Research At MIT, US
New groupCRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
Randall J. Platt · Cell
Cites (sentence not available)2,001 citations overall
-
Jennifer A. Doudna
Howard Hughes Medical Institute, US
Original teamThe new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna · Science
Cites (sentence not available)7,065 citations overall ; cited by 6 later papers in this map
-
Feng Zhang
Broad Institute, US
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Silvana Konermann · Nature
Cites (sentence not available)2,825 citations overall ; cited by 2 later papers in this map
-
Shengdar Q. Tsai
Harvard University, US
New groupGUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Shengdar Q. Tsai · Nature Biotechnology
Cites (sentence not available)2,269 citations overall ; cited by 7 later papers in this map
2015 4 papers
-
Feng Zhang
Broad Institute, US
In vivo genome editing using Staphylococcus aureus Cas9
F. Ann Ran · Nature
“Type II CRISPR-Cas systems require only two main components for eukaryotic genome editing: a Cas9 enzyme, and a chimeric single guide RNA (sgRNA)[*] derived from the CRISPR RNA (crRNA) and the noncoding trans-activating crRNA (tracrRNA)4,20...”
Cites as background2,688 citations overall ; cited by 6 later papers in this map
-
Yao‐Guang Liu
South China Agricultural University, CN
New groupXingliang Ma · Molecular Plant
Cites (sentence not available)2,381 citations overall
-
Feng Zhang
Broad Institute, US
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Bernd Zetsche · Cell
Cites (sentence not available)4,808 citations overall ; cited by 8 later papers in this map
-
Eugene V. Koonin
National Institutes of Health, US
Original teamAn updated evolutionary classification of CRISPR–Cas systems
Kira S. Makarova · Nature Reviews Microbiology
Cites (sentence not available)2,516 citations overall ; cited by 6 later papers in this map
2016 4 papers
-
J. Keith Joung
Harvard University, US
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
Benjamin P. Kleinstiver · Nature
Cites (sentence not available)2,670 citations overall ; cited by 7 later papers in this map
-
John G. Doench
Broad Institute, US
New groupOptimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
John G. Doench · Nature Biotechnology
“The Cas9 protein, an RNA-directed DNA endonuclease, is a powerful tool for manipulating the genome[*]-4.”
Cites as background4,634 citations overall ; cited by 3 later papers in this map
-
David R. Liu
Howard Hughes Medical Institute, US
New groupProgrammable editing of a target base in genomic DNA without double-stranded DNA cleavage
Alexis C. Komor · Nature
“Catalytically-dead Cas9 (dCas9), which contains Asp10Ala and His840Ala mutations that inactivate its nuclease activity, retains its ability to bind DNA in a guide RNA-programmed manner but does not cleave the DNA backbone.[*] In principle,...”
Cites as background5,439 citations overall ; cited by 6 later papers in this map
-
Eugene V. Koonin
National Institutes of Health, US
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
Omar O. Abudayyeh · Science
Cites (sentence not available)2,361 citations overall ; cited by 2 later papers in this map
2017 1 paper
-
Jennifer A. Doudna
QB3, US
Original teamCRISPR–Cas9 Structures and Mechanisms
Fuguo Jiang · Annual Review of Biophysics
Cites (sentence not available)2,029 citations overall ; cited by 1 later paper in this map
2018 1 paper
-
Janice S. Chen
University of California, Berkeley, US
New group Original teamCRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Janice S. Chen · Science
Cites (sentence not available)4,512 citations overall ; cited by 3 later papers in this map
2019 1 paper
-
David R. Liu
Broad Institute, US
Search-and-replace genome editing without double-strand breaks or donor DNA
Andrew V. Anzalone · Nature
“Programmable nucleases such as CRISPR-Cas9 make double-strand DNA breaks (DSBs) that can disrupt genes by inducing mixtures of insertions and deletions (indels) at target sites[*]–4.”
Cites as background4,762 citations overall ; cited by 6 later papers in this map
2020 3 papers
-
Daniel J. Siegwart
Harold C. Simmons Comprehensive Cancer Center, US
New groupQiang Cheng · Nature Nanotechnology
Cites (sentence not available)2,380 citations overall ; cited by 1 later paper in this map
-
David R. Liu
Broad Institute, US
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
Andrew V. Anzalone · Nature Biotechnology
Cites (sentence not available)2,239 citations overall ; cited by 2 later papers in this map
-
Thomas C. Roberts
University of Oxford, GB
New groupAdvances in oligonucleotide drug delivery
Thomas C. Roberts · Nature Reviews Drug Discovery
Cites (sentence not available)2,012 citations overall
2023 1 paper
-
Alexander W. Rives
New York University, US
New groupEvolutionary-scale prediction of atomic-level protein structure with a language model
Zeming Lin · Science
Cites (sentence not available)5,592 citations overall ; cited by 2 later papers in this map
2026 20 papers
-
Xinrui Wang
Jilin University, CN
New groupA DNAzyme-activated engineered crRNA enables CRISPR-Cas12a biosensing of ALP and S. aureus
Xinrui Wang · Biosensors and Bioelectronics
Cites (sentence not available)0 citations overall
-
George P. Lisi
Brown University, US
New groupAlexa L Knight · JACS Au
Cites (sentence not available)0 citations overall
-
Zheran Liu
Sichuan University, CN
New groupPeng Huang · Experimental Hematology and Oncology
Cites (sentence not available)0 citations overall
-
Abdoulaye Diabaté
Institut de Recherche en Sciences de la Santé, BF
New groupAchaz A. M. Agolinou ·
Cites (sentence not available)0 citations overall
-
Nuo Si
Chinese Academy of Medical Sciences & Peking Union Medical College, CN
New groupJiawei Du · Genes
Cites (sentence not available)0 citations overall
-
Marco Garbin
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, IT
New groupMarco Garbin · Medical Hypotheses
Cites (sentence not available)0 citations overall
-
Xuyang Lu
Jiangnan University, CN
New groupIn Vivo Continuous Evolution Systems: Overview, Principles and Applications
Xuyang Lu · ACS Synthetic Biology
Cites (sentence not available)0 citations overall
-
Simon Fischer
Boehringer Ingelheim (Germany), DE
New groupJuergen Fieder · Critical Reviews in Biotechnology
Cites (sentence not available)0 citations overall
-
Chaolong Rao
Chengdu University of Traditional Chinese Medicine, CN
New groupTian Leng · DARU Journal of Pharmaceutical Sciences
“For instance, targeting these highly expressed “sponge” RNA molecules or designing antisense oligonucleotides that can specifically bind to such “sponge” RNAs may serve as an effective strategy to restore the tumor-suppressive activity of m...”
Cites as background0 citations overall
-
Diana Lee Farmer
Shriners Hospitals for Children - Northern California, US
New groupBioengineering strategies for prenatal therapy
Elizabeth Reynolds · Nature Reviews Bioengineering
Cites (sentence not available)0 citations overall
-
Hao Yin
Wuhan University, CN
New groupEfficient and precise large-scale genomic duplication using amplification editing
Sisi Xie · Nature Protocols
Cites (sentence not available)0 citations overall
-
Yeni Wahyuni Hartati
Padjadjaran University, ID
New groupClianta Yudin Kharismasari · ADMET & DMPK
“The loop structure is important for Cas protein binding, structural stabilization of the ribonucleoprotein complex, and activation of nuclease activity after target recognition [27-29].”
Cites as background0 citations overall
-
Abdullah Mohammad Shohael
Jahangirnagar University, BD
New groupMd. Nazmussakib Shuvo · Crop Breeding Genetics and Genomics
“In contrast, CRISPR-Cas genome editing instead uses an RNA-programmed nuclease whose specificity is dictated by guide RNA (gRNA) base pairing to the target DNA [101].”
Cites as background0 citations overall
-
Hoe‐Han Goh
National University of Malaysia, MY
New groupSystems biology and synthetic engineering of probiotic yeasts
Saqib Ali · Biotechnology Advances
Cites (sentence not available)0 citations overall
-
Edyta Juszczuk‐Kubiak
Institute of Agricultural and Food Biotechnology, PL
New groupCRISPR/Cas in food microbial biotechnology: from genome editing to precision microbiology
Edyta Juszczuk‐Kubiak · Frontiers in Microbiology
Cites (sentence not available)0 citations overall
-
Daniel H. Wolbrom
Columbia University, US
New groupNonischemic and normothermic beating cardiac xenotransplantation
Daniel H. Wolbrom · Frontiers in Transplantation
Cites (sentence not available)0 citations overall
-
Raúl Ruiz
Universitat de València, ES
New groupComputational Design of Prokaryotic Translation Regulation Based on RNA-Binding Proteins
Raúl Ruiz · Methods in molecular biology
Cites (sentence not available)0 citations overall
-
Zhu Baosheng
Kunming University of Science and Technology, CN
New groupResearch progress of gene correction for genetic diseases via in vivo prime editing
Shuran Zhang · Molecular Genetics and Genomics
“The CRISPR-Cas9 was recently developed and become the most widely used platforms of genome engineering (Jinek et al. 2012; Hryhorowicz et al. 2016; Kantor et al. 2020).”
Cites as background0 citations overall
-
Qing Chi Xu
Nanjing Normal University, CN
New groupRubing Du · Journal of Agricultural and Food Chemistry
Cites (sentence not available)0 citations overall
-
Eric N. Olson
The University of Texas Southwestern Medical Center, US
New groupYu-Chung Pien · Journal of Clinical Investigation
Cites (sentence not available)0 citations overall
D. Research group influence map
Groups are identified by the corresponding (or last) author of each citing paper in this map. Two groups are shown as collaborating only when their papers share an author.
| Lead author | Institution, country | Years | Papers and relationship to the original | Collaborates with |
|---|---|---|---|---|
| Le Cong | Broad Institute, US | 2013 | Multiplex Genome Engineering Using CRISPR/Cas Systems (2013) · Cites (sentence not available) | Feng Zhang, Rudolf Jaenisch, David Bikard, Phillip A. Sharp, Eugene V. Koonin |
| Feng Zhang | Broad Institute, US | 2013–2015 | Genome engineering using the CRISPR-Cas9 system (2013) · Cites (sentence not available) Development and Applications of CRISPR-Cas9 for Genome Engineering (2014) · Cites (sentence not available) Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells (2013) · Cites (sentence not available) Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas Syste... (2015) · Cites (sentence not available) DNA targeting specificity of RNA-guided Cas9 nucleases (2013) · Cites (sentence not available) Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing S... (2013) · Cites (sentence not available) Genome-scale transcriptional activation by an engineered CRISPR-Cas9 c... (2014) · Cites (sentence not available) In vivo genome editing using Staphylococcus aureus Cas9 (2015) · Cites as background Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA (2014) · Cites (sentence not available) | Le Cong, Rudolf Jaenisch, David M. Sabatini, David Bikard, Phillip A. Sharp, Eugene V. Koonin, John G. Doench |
| Prashant Mali | Harvard University, US | 2013 | RNA-Guided Human Genome Engineering via Cas9 (2013) · Cites (sentence not available) | — |
| Jennifer A. Doudnaoriginal team | Howard Hughes Medical Institute, US | 2013–2017 | The new frontier of genome engineering with CRISPR-Cas9 (2014) · Cites (sentence not available) RNA-programmed genome editing in human cells (2013) · Cites (sentence not available) CRISPR–Cas9 Structures and Mechanisms (2017) · Cites (sentence not available) | Lei S. Qi, Jonathan S. Weissman, Eugene V. Koonin, Janice S. Chen |
| Lei S. Qioriginal team | QB3, US | 2013 | Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Con... (2013) · Cites (sentence not available) Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized... (2013) · Cites (sentence not available) | Jennifer A. Doudna, Jonathan S. Weissman, Janice S. Chen |
| Carlos F. Barbas | Scripps Research Institute, US | 2013 | ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering (2013) · Cites (sentence not available) | — |
| Jonathan S. Weissmanoriginal team | QB3, US | 2013 | CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Euka... (2013) · Cites (sentence not available) | Jennifer A. Doudna, Lei S. Qi, Janice S. Chen |
| Rudolf Jaenisch | Whitehead Institute for Biomedical Research, US | 2013 | One-Step Generation of Mice Carrying Mutations in Multiple Genes by CR... (2013) · Cites (sentence not available) | Le Cong, Feng Zhang, David Bikard, Phillip A. Sharp, Eugene V. Koonin |
| J. Keith Joung | Harvard University, US | 2013–2016 | High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases... (2013) · Cites as background CRISPR-Cas systems for editing, regulating and targeting genomes (2014) · Cites (sentence not available) High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off... (2016) · Cites (sentence not available) | J-R Joanna Yeh, Shengdar Q. Tsai, Jeffry D. Sander |
| J-R Joanna Yeh | Harvard University, US | 2013 | Efficient genome editing in zebrafish using a CRISPR-Cas system (2013) · Cites (sentence not available) | J. Keith Joung, Shengdar Q. Tsai, Jeffry D. Sander |
| David M. Sabatini | Broad Institute, US | 2013 | Genetic Screens in Human Cells Using the CRISPR-Cas9 System (2013) · Cites (sentence not available) | Feng Zhang, Eugene V. Koonin |
| David Bikard | Rockefeller University, US | 2013 | RNA-guided editing of bacterial genomes using CRISPR-Cas systems (2013) · Cites (sentence not available) | Le Cong, Feng Zhang, Rudolf Jaenisch, Phillip A. Sharp, Eugene V. Koonin |
| Sangsu Bae | Seoul National University, KR | 2014 | Cas-OFFinder: a fast and versatile algorithm that searches for potenti... (2014) · Cites (sentence not available) | — |
| Shengdar Q. Tsai | Harvard University, US | 2014 | GUIDE-seq enables genome-wide profiling of off-target cleavage by CRIS... (2014) · Cites (sentence not available) | J. Keith Joung, J-R Joanna Yeh, Jeffry D. Sander |
| Phillip A. Sharp | Koch Institute for Integrative Cancer Research At MIT, US | 2014 | CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling (2014) · Cites (sentence not available) | Le Cong, Feng Zhang, Rudolf Jaenisch, David Bikard, Eugene V. Koonin, Thomas C. Roberts |
| Jeffry D. Sander | Harvard University, US | 2014 | Improving CRISPR-Cas nuclease specificity using truncated guide RNAs (2014) · Cites (sentence not available) | J. Keith Joung, J-R Joanna Yeh, Shengdar Q. Tsai |
| Eugene V. Kooninoriginal team | National Institutes of Health, US | 2015–2016 | An updated evolutionary classification of CRISPR–Cas systems (2015) · Cites (sentence not available) C2c2 is a single-component programmable RNA-guided RNA-targeting CRISP... (2016) · Cites (sentence not available) | Le Cong, Feng Zhang, Jennifer A. Doudna, Rudolf Jaenisch, David M. Sabatini, David Bikard, Phillip A. Sharp |
| Yao‐Guang Liu | South China Agricultural University, CN | 2015 | A Robust CRISPR/Cas9 System for Convenient, High-Efficiency Multiplex... (2015) · Cites (sentence not available) | — |
| David R. Liu | Broad Institute, US | 2016–2020 | Programmable editing of a target base in genomic DNA without double-st... (2016) · Cites as background Search-and-replace genome editing without double-strand breaks or dono... (2019) · Cites as background Genome editing with CRISPR–Cas nucleases, base editors, transposases a... (2020) · Cites (sentence not available) | — |
| John G. Doench | Broad Institute, US | 2016 | Optimized sgRNA design to maximize activity and minimize off-target ef... (2016) · Cites as background | Feng Zhang |
| Janice S. Chenoriginal team | University of California, Berkeley, US | 2018 | CRISPR-Cas12a target binding unleashes indiscriminate single-stranded... (2018) · Cites (sentence not available) | Jennifer A. Doudna, Lei S. Qi, Jonathan S. Weissman |
| Daniel J. Siegwart | Harold C. Simmons Comprehensive Cancer Center, US | 2020 | Selective organ targeting (SORT) nanoparticles for tissue-specific mRN... (2020) · Cites (sentence not available) | — |
| Thomas C. Roberts | University of Oxford, GB | 2020 | Advances in oligonucleotide drug delivery (2020) · Cites (sentence not available) | Phillip A. Sharp |
| Alexander W. Rives | New York University, US | 2023 | Evolutionary-scale prediction of atomic-level protein structure with a... (2023) · Cites (sentence not available) | — |
| Eric N. Olson | The University of Texas Southwestern Medical Center, US | 2026 | A single liver-sparing myotropic AAV ameliorates muscular dystrophy in... (2026) · Cites (sentence not available) | — |
| Qing Chi Xu | Nanjing Normal University, CN | 2026 | Clustered Regularly Interspaced Palindromic Repeats–Cas Genome-Editing... (2026) · Cites (sentence not available) | — |
| Edyta Juszczuk‐Kubiak | Institute of Agricultural and Food Biotechnology, PL | 2026 | CRISPR/Cas in food microbial biotechnology: from genome editing to pre... (2026) · Cites (sentence not available) | — |
| Daniel H. Wolbrom | Columbia University, US | 2026 | Nonischemic and normothermic beating cardiac xenotransplantation (2026) · Cites (sentence not available) | — |
| Raúl Ruiz | Universitat de València, ES | 2026 | Computational Design of Prokaryotic Translation Regulation Based on RN... (2026) · Cites (sentence not available) | — |
| Zhu Baosheng | Kunming University of Science and Technology, CN | 2026 | Research progress of gene correction for genetic diseases via in vivo... (2026) · Cites as background | — |
| Hoe‐Han Goh | National University of Malaysia, MY | 2026 | Systems biology and synthetic engineering of probiotic yeasts (2026) · Cites (sentence not available) | — |
| Yeni Wahyuni Hartati | Padjadjaran University, ID | 2026 | CRISPR/Cas12-powered electrochemical biosensor for chikungunya virus D... (2026) · Cites as background | — |
| Abdullah Mohammad Shohael | Jahangirnagar University, BD | 2026 | Integrating Frontier Technologies to Achieve Semi-Dwarfism in Rice: Hi... (2026) · Cites as background | — |
| Diana Lee Farmer | Shriners Hospitals for Children - Northern California, US | 2026 | Bioengineering strategies for prenatal therapy (2026) · Cites (sentence not available) | — |
| Hao Yin | Wuhan University, CN | 2026 | Efficient and precise large-scale genomic duplication using amplificat... (2026) · Cites (sentence not available) | — |
| Simon Fischer | Boehringer Ingelheim (Germany), DE | 2026 | The historical evolution of CHO cell line development for biologics pr... (2026) · Cites (sentence not available) | — |
| Chaolong Rao | Chengdu University of Traditional Chinese Medicine, CN | 2026 | miR-138-5p: From Multidimensional Tumor-Suppressive Regulatory Network... (2026) · Cites as background | — |
| Marco Garbin | Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, IT | 2026 | ORFan genes and capsid architectures in giant viruses: two structure-g... (2026) · Cites (sentence not available) | — |
| Xuyang Lu | Jiangnan University, CN | 2026 | In Vivo Continuous Evolution Systems: Overview, Principles and Applica... (2026) · Cites (sentence not available) | — |
| George P. Lisi | Brown University, US | 2026 | Visualizing the Atomic-Level Impact of Anti-CRISPR II–C1 Inhibition on... (2026) · Cites (sentence not available) | — |
| Zheran Liu | Sichuan University, CN | 2026 | Innovations and emerging trends in adoptive cell therapies for solid t... (2026) · Cites (sentence not available) | — |
| Abdoulaye Diabaté | Institut de Recherche en Sciences de la Santé, BF | 2026 | Identification and evaluation of a gRNA targeting the Nudel gene to ad... (2026) · Cites (sentence not available) | — |
| Nuo Si | Chinese Academy of Medical Sciences & Peking Union Medical College, CN | 2026 | Precision Gene Therapy for Monogenic Neurological Disorders: Emerging... (2026) · Cites (sentence not available) | — |
| Xinrui Wang | Jilin University, CN | 2026 | A DNAzyme-activated engineered crRNA enables CRISPR-Cas12a biosensing... (2026) · Cites (sentence not available) | — |
E. Research opportunity map
Research opportunities are written by AI and are not available for this map.
F. Comprehensive citation table
The 15 most-cited studies the original builds on, and 60 of its 17,118 citing papers (the most cited and the most recent). 9 have a citing sentence; the rest are marked “Cites (sentence not available)”.
| Role | First author | Year | Title | Journal | DOI | Institution | Relationship | Evidence (citing sentence) |
|---|---|---|---|---|---|---|---|---|
| Foundation | Joseph Sambrook | 1989 | Molecular Cloning: A Laboratory Manual | UCLA - Biblioteca de Ciencias de la Salud | Cited by the original | |||
| Foundation | Benjamin P. Lewis | 2005 | Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets | Cell | 10.1016/j.cell.2004.12.035 | Massachusetts Institute of Technology | Cited by the original | |
| Foundation | Rodolphe Barrangou | 2007 | CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes | Science | 10.1126/science.1138140 | Université Laval | Cited by the original | |
| Foundation | György Hutvágner | 2007 | Argonaute proteins: key players in RNA silencing | Nature Reviews Molecular Cell Biology | 10.1038/nrm2321 | Hôtel-Dieu de Québec | Cited by the original | |
| Foundation | Hélène Deveau | 2007 | Phage Response to CRISPR-Encoded Resistance in Streptococcus thermophilus | Journal of Bacteriology | 10.1128/jb.01412-07 | Université Laval | Cited by the original | |
| Foundation | Stan J. J. Brouns | 2008 | Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes | Science | 10.1126/science.1159689 | National Institutes of Health | Cited by the original | |
| Foundation | Francisco J. M. Mojica | 2009 | Short motif sequences determine the targets of the prokaryotic CRISPR defence system | Microbiology | 10.1099/mic.0.023960-0 | University of Alicante | Cited by the original | |
| Foundation | Kévin Darty | 2009 | VARNA: Interactive drawing and editing of the RNA secondary structure | Bioinformatics | 10.1093/bioinformatics/btp250 | Université Paris-Sud | Cited by the original | |
| Foundation | Josiane E. Garneau | 2010 | The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA | Nature | 10.1038/nature09523 | Université Laval | Cited by the original | |
| Foundation | Fyodor D. Urnov | 2010 | Genome editing with engineered zinc finger nucleases | Nature Reviews Genetics | 10.1038/nrg2842 | Sangamo BioSciences (United States) | Cited by the original | |
| Foundation | Jeffrey C. Miller | 2010 | A TALE nuclease architecture for efficient genome editing | Nature Biotechnology | 10.1038/nbt.1755 | Sangamo BioSciences (United States) | Cited by the original | |
| Foundation | Michelle L. Christian | 2010 | Targeting DNA Double-Strand Breaks with TAL Effector Nucleases | Genetics | 10.1534/genetics.110.120717 | University of Minnesota | Cited by the original | |
| Foundation (same team) | Elitza M. Deltcheva | 2011 | CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III | Nature | 10.1038/nature09886 | University of Vienna | Cited by the original | |
| Foundation (same team) | Kira S. Makarova | 2011 | Evolution and classification of the CRISPR–Cas systems | Nature Reviews Microbiology | 10.1038/nrmicro2577 | National Institutes of Health | Cited by the original | |
| Foundation (same team) | Blake Wiedenheft | 2012 | RNA-guided genetic silencing systems in bacteria and archaea | Nature | 10.1038/nature10886 | Howard Hughes Medical Institute | Cited by the original | |
| Citing paper | Le Cong | 2013 | Multiplex Genome Engineering Using CRISPR/Cas Systems | Science | 10.1126/science.1231143 | Broad Institute | Cites (sentence not available) | |
| Citing paper | F. Ann Ran | 2013 | Genome engineering using the CRISPR-Cas9 system | Nature Protocols | 10.1038/nprot.2013.143 | Broad Institute | Cites (sentence not available) | |
| Citing paper | Prashant Mali | 2013 | RNA-Guided Human Genome Engineering via Cas9 | Science | 10.1126/science.1232033 | Harvard University | Cites (sentence not available) | |
| Citing paper | Ophir Shalem | 2013 | Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells | Science | 10.1126/science.1247005 | Broad Institute | Cites (sentence not available) | |
| Citing paper (same team) | Lei S. Qi | 2013 | Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression | Cell | 10.1016/j.cell.2013.02.022 | QB3 | Cites (sentence not available) | |
| Citing paper | Patrick D. Hsu | 2013 | DNA targeting specificity of RNA-guided Cas9 nucleases | Nature Biotechnology | 10.1038/nbt.2647 | Broad Institute | Cites (sentence not available) | |
| Citing paper | Thomas Gaj | 2013 | ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering | Trends in biotechnology | 10.1016/j.tibtech.2013.04.004 | Scripps Research Institute | Cites (sentence not available) | |
| Citing paper (same team) | Luke A. Gilbert | 2013 | CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes | Cell | 10.1016/j.cell.2013.06.044 | QB3 | Cites (sentence not available) | |
| Citing paper | Haoyi Wang | 2013 | One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering | Cell | 10.1016/j.cell.2013.04.025 | Whitehead Institute for Biomedical Research | Cites (sentence not available) | |
| Citing paper | F. Ann Ran | 2013 | Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity | Cell | 10.1016/j.cell.2013.08.021 | Broad Institute | Cites (sentence not available) | |
| Citing paper | Yanfang Fu | 2013 | High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells | Nature Biotechnology | 10.1038/nbt.2623 | Harvard University | Cites as background | The Cas9 nuclease from S. pyogenes (hereafter simply Cas9) can be guided via simple base pair complementarity between the first 20 nucleotides of an engineered gRNA and a target genomic DNA sequence of interest that lies next to a protospacer adjacent motif (PAM) matching the sequence NGG5–12, [*] (Supplementary Fig. 1).Source: Europe PMC |
| Citing paper | Woong Y. Hwang | 2013 | Efficient genome editing in zebrafish using a CRISPR-Cas system | Nature Biotechnology | 10.1038/nbt.2501 | Harvard University | Cites (sentence not available) | |
| Citing paper | Wang Tim | 2013 | Genetic Screens in Human Cells Using the CRISPR-Cas9 System | Science | 10.1126/science.1246981 | Broad Institute | Cites (sentence not available) | |
| Citing paper | Wenyan Jiang | 2013 | RNA-guided editing of bacterial genomes using CRISPR-Cas systems | Nature Biotechnology | 10.1038/nbt.2508 | Rockefeller University | Cites (sentence not available) | |
| Citing paper (same team) | Martin Jínek | 2013 | RNA-programmed genome editing in human cells | eLife | 10.7554/elife.00471 | Howard Hughes Medical Institute | Cites (sentence not available) | |
| Citing paper | Baohui Chen | 2013 | Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System | Cell | 10.1016/j.cell.2013.12.001 | QB3 | Cites (sentence not available) | |
| Citing paper (same team) | Jennifer A. Doudna | 2014 | The new frontier of genome engineering with CRISPR-Cas9 | Science | 10.1126/science.1258096 | Howard Hughes Medical Institute | Cites (sentence not available) | |
| Citing paper | Patrick D. Hsu | 2014 | Development and Applications of CRISPR-Cas9 for Genome Engineering | Cell | 10.1016/j.cell.2014.05.010 | Broad Institute | Cites (sentence not available) | |
| Citing paper | Jeffry D. Sander | 2014 | CRISPR-Cas systems for editing, regulating and targeting genomes | Nature Biotechnology | 10.1038/nbt.2842 | Harvard University | Cites (sentence not available) | |
| Citing paper | Silvana Konermann | 2014 | Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex | Nature | 10.1038/nature14136 | Broad Institute | Cites (sentence not available) | |
| Citing paper | Sangsu Bae | 2014 | Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases | Bioinformatics | 10.1093/bioinformatics/btu048 | Seoul National University | Cites (sentence not available) | |
| Citing paper | Hiroshi Nishimasu | 2014 | Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA | Cell | 10.1016/j.cell.2014.02.001 | Broad Institute | Cites (sentence not available) | |
| Citing paper | Shengdar Q. Tsai | 2014 | GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases | Nature Biotechnology | 10.1038/nbt.3117 | Harvard University | Cites (sentence not available) | |
| Citing paper | Randall J. Platt | 2014 | CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling | Cell | 10.1016/j.cell.2014.09.014 | Koch Institute for Integrative Cancer Research At MIT | Cites (sentence not available) | |
| Citing paper | Yanfang Fu | 2014 | Improving CRISPR-Cas nuclease specificity using truncated guide RNAs | Nature Biotechnology | 10.1038/nbt.2808 | Harvard University | Cites (sentence not available) | |
| Citing paper | Bernd Zetsche | 2015 | Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System | Cell | 10.1016/j.cell.2015.09.038 | Broad Institute | Cites (sentence not available) | |
| Citing paper | F. Ann Ran | 2015 | In vivo genome editing using Staphylococcus aureus Cas9 | Nature | 10.1038/nature14299 | Broad Institute | Cites as background | Type II CRISPR-Cas systems require only two main components for eukaryotic genome editing: a Cas9 enzyme, and a chimeric single guide RNA (sgRNA)[*] derived from the CRISPR RNA (crRNA) and the noncoding trans-activating crRNA (tracrRNA)4,20.Source: Europe PMC |
| Citing paper (same team) | Kira S. Makarova | 2015 | An updated evolutionary classification of CRISPR–Cas systems | Nature Reviews Microbiology | 10.1038/nrmicro3569 | National Institutes of Health | Cites (sentence not available) | |
| Citing paper | Xingliang Ma | 2015 | A Robust CRISPR/Cas9 System for Convenient, High-Efficiency Multiplex Genome Editing in Monocot and Dicot Plants | Molecular Plant | 10.1016/j.molp.2015.04.007 | South China Agricultural University | Cites (sentence not available) | |
| Citing paper | Alexis C. Komor | 2016 | Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage | Nature | 10.1038/nature17946 | Howard Hughes Medical Institute | Cites as background | Catalytically-dead Cas9 (dCas9), which contains Asp10Ala and His840Ala mutations that inactivate its nuclease activity, retains its ability to bind DNA in a guide RNA-programmed manner but does not cleave the DNA backbone.[*] In principle, conjugation of dCas9 with an enzymatic or chemical catalyst that mediates the direct conversion of one base to another could enable RNA-programmed DNA base editing.Source: Europe PMC |
| Citing paper | John G. Doench | 2016 | Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 | Nature Biotechnology | 10.1038/nbt.3437 | Broad Institute | Cites as background | The Cas9 protein, an RNA-directed DNA endonuclease, is a powerful tool for manipulating the genome[*]-4.Source: Europe PMC |
| Citing paper | Benjamin P. Kleinstiver | 2016 | High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects | Nature | 10.1038/nature16526 | Harvard University | Cites (sentence not available) | |
| Citing paper | Omar O. Abudayyeh | 2016 | C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector | Science | 10.1126/science.aaf5573 | National Institutes of Health | Cites (sentence not available) | |
| Citing paper (same team) | Fuguo Jiang | 2017 | CRISPR–Cas9 Structures and Mechanisms | Annual Review of Biophysics | 10.1146/annurev-biophys-062215-010822 | QB3 | Cites (sentence not available) | |
| Citing paper (same team) | Janice S. Chen | 2018 | CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity | Science | 10.1126/science.aar6245 | University of California, Berkeley | Cites (sentence not available) | |
| Citing paper | Andrew V. Anzalone | 2019 | Search-and-replace genome editing without double-strand breaks or donor DNA | Nature | 10.1038/s41586-019-1711-4 | Broad Institute | Cites as background | Programmable nucleases such as CRISPR-Cas9 make double-strand DNA breaks (DSBs) that can disrupt genes by inducing mixtures of insertions and deletions (indels) at target sites[*]–4.Source: Europe PMC |
| Citing paper | Qiang Cheng | 2020 | Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing | Nature Nanotechnology | 10.1038/s41565-020-0669-6 | Harold C. Simmons Comprehensive Cancer Center | Cites (sentence not available) | |
| Citing paper | Andrew V. Anzalone | 2020 | Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors | Nature Biotechnology | 10.1038/s41587-020-0561-9 | Broad Institute | Cites (sentence not available) | |
| Citing paper | Thomas C. Roberts | 2020 | Advances in oligonucleotide drug delivery | Nature Reviews Drug Discovery | 10.1038/s41573-020-0075-7 | University of Oxford | Cites (sentence not available) | |
| Citing paper | Zeming Lin | 2023 | Evolutionary-scale prediction of atomic-level protein structure with a language model | Science | 10.1126/science.ade2574 | New York University | Cites (sentence not available) | |
| Citing paper | Yu-Chung Pien | 2026 | A single liver-sparing myotropic AAV ameliorates muscular dystrophy in humanized mice by base editing | Journal of Clinical Investigation | 10.1172/jci202378 | The University of Texas Southwestern Medical Center | Cites (sentence not available) | |
| Citing paper | Rubing Du | 2026 | Clustered Regularly Interspaced Palindromic Repeats–Cas Genome-Editing Systems in Filamentous Fungi: Current Tools, Optimization Strategies, and Future Perspectives | Journal of Agricultural and Food Chemistry | 10.1021/acs.jafc.6c12748 | Nanjing Normal University | Cites (sentence not available) | |
| Citing paper | Edyta Juszczuk‐Kubiak | 2026 | CRISPR/Cas in food microbial biotechnology: from genome editing to precision microbiology | Frontiers in Microbiology | 10.3389/fmicb.2026.1996037 | Institute of Agricultural and Food Biotechnology | Cites (sentence not available) | |
| Citing paper | Daniel H. Wolbrom | 2026 | Nonischemic and normothermic beating cardiac xenotransplantation | Frontiers in Transplantation | 10.3389/frtra.2026.1984456 | Columbia University | Cites (sentence not available) | |
| Citing paper | Raúl Ruiz | 2026 | Computational Design of Prokaryotic Translation Regulation Based on RNA-Binding Proteins | Methods in molecular biology | 10.1007/978-1-0716-5583-2_4 | Universitat de València | Cites (sentence not available) | |
| Citing paper | Shuran Zhang | 2026 | Research progress of gene correction for genetic diseases via in vivo prime editing | Molecular Genetics and Genomics | 10.1007/s00438-026-02535-8 | Kunming University of Science and Technology | Cites as background | The CRISPR-Cas9 was recently developed and become the most widely used platforms of genome engineering (Jinek et al. 2012; Hryhorowicz et al. 2016; Kantor et al. 2020).Source: Semantic Scholar |
| Citing paper | Saqib Ali | 2026 | Systems biology and synthetic engineering of probiotic yeasts | Biotechnology Advances | 10.1016/j.biotechadv.2026.109084 | National University of Malaysia | Cites (sentence not available) | |
| Citing paper | Clianta Yudin Kharismasari | 2026 | CRISPR/Cas12-powered electrochemical biosensor for chikungunya virus DNA detection using gold-modified screen-printed carbon electrodes | ADMET & DMPK | 10.5599/admet.3564 | Padjadjaran University | Cites as background | The loop structure is important for Cas protein binding, structural stabilization of the ribonucleoprotein complex, and activation of nuclease activity after target recognition [27-29].Source: Semantic Scholar |
| Citing paper | Md. Nazmussakib Shuvo | 2026 | Integrating Frontier Technologies to Achieve Semi-Dwarfism in Rice: Highlights on Genome Editing and Artificial Intelligence | Crop Breeding Genetics and Genomics | 10.20900/cbgg20260024 | Jahangirnagar University | Cites as background | In contrast, CRISPR-Cas genome editing instead uses an RNA-programmed nuclease whose specificity is dictated by guide RNA (gRNA) base pairing to the target DNA [101].Source: Semantic Scholar |
| Citing paper | Elizabeth Reynolds | 2026 | Bioengineering strategies for prenatal therapy | Nature Reviews Bioengineering | 10.1038/s44222-026-00501-y | Shriners Hospitals for Children - Northern California | Cites (sentence not available) | |
| Citing paper | Sisi Xie | 2026 | Efficient and precise large-scale genomic duplication using amplification editing | Nature Protocols | 10.1038/s41596-026-01454-7 | Wuhan University | Cites (sentence not available) | |
| Citing paper | Juergen Fieder | 2026 | The historical evolution of CHO cell line development for biologics production: 60 years and still counting | Critical Reviews in Biotechnology | 10.1080/07388551.2026.2738418 | Boehringer Ingelheim (Germany) | Cites (sentence not available) | |
| Citing paper | Tian Leng | 2026 | miR-138-5p: From Multidimensional Tumor-Suppressive Regulatory Networks to Nanocarrier-Based Delivery for Solid Tumor Therapy | DARU Journal of Pharmaceutical Sciences | 10.1007/s40199-026-00683-1 | Chengdu University of Traditional Chinese Medicine | Cites as background | For instance, targeting these highly expressed “sponge” RNA molecules or designing antisense oligonucleotides that can specifically bind to such “sponge” RNAs may serve as an effective strategy to restore the tumor-suppressive activity of miR-138-5p [55, 56, 58, 59].Source: Semantic Scholar |
| Citing paper | Marco Garbin | 2026 | ORFan genes and capsid architectures in giant viruses: two structure-guided hypotheses for biomedical innovation | Medical Hypotheses | 10.1016/j.mehy.2026.112218 | Università degli Studi del Piemonte Orientale “Amedeo Avogadro” | Cites (sentence not available) | |
| Citing paper | Xuyang Lu | 2026 | In Vivo Continuous Evolution Systems: Overview, Principles and Applications | ACS Synthetic Biology | 10.1021/acssynbio.6c00481 | Jiangnan University | Cites (sentence not available) | |
| Citing paper | Alexa L Knight | 2026 | Visualizing the Atomic-Level Impact of Anti-CRISPR II–C1 Inhibition on Geo Cas9 with Integrated Structural Biophysics | JACS Au | 10.1021/jacsau.6c00870 | Brown University | Cites (sentence not available) | |
| Citing paper | Peng Huang | 2026 | Innovations and emerging trends in adoptive cell therapies for solid tumors: engineering strategies and clinical translation | Experimental Hematology and Oncology | 10.1186/s40164-026-00848-3 | Sichuan University | Cites (sentence not available) | |
| Citing paper | Achaz A. M. Agolinou | 2026 | Identification and evaluation of a gRNA targeting the Nudel gene to adapt a gene drive system from Anopheles gambiae to Anopheles funestus for genetic control | 10.12688/verixiv.3174.2 | Institut de Recherche en Sciences de la Santé | Cites (sentence not available) | ||
| Citing paper | Jiawei Du | 2026 | Precision Gene Therapy for Monogenic Neurological Disorders: Emerging Technologies, Safety, and Mechanism–Modality Matching | Genes | 10.3390/genes17111321 | Chinese Academy of Medical Sciences & Peking Union Medical College | Cites (sentence not available) | |
| Citing paper | Xinrui Wang | 2026 | A DNAzyme-activated engineered crRNA enables CRISPR-Cas12a biosensing of ALP and S. aureus | Biosensors and Bioelectronics | 10.1016/j.bios.2026.119360 | Jilin University | Cites (sentence not available) |
G. Research strategy report
Research proposals are written by AI and are not available for this map.
Quantitative research impact
- Total citations
- 17,118
- Verified, OpenAlex
- Citing papers in this map
- 60
- Most cited + most recent
- With citing sentence
- 9
- Semantic Scholar, Europe PMC
- Distinct research groups
- 44
- In this map
- Self-citations
- 7
- Citing papers sharing an author
Citations per year
All citing works in OpenAlex, 2 Nov 2026; the current year is incomplete.
- 1889 1
- 1952 1
- 1965 1
- 1978 1
- 1982 1
- 1983 1+0%
- 1989 1
- 1995 1
- 1999 2
- 2002 1
- 2005 1
- 2006 1+0%
- 2008 2
- 2010 1
- 2011 1+0%
- 2012 29+2800%
- 2013 231+697%
- 2014 467+102%
- 2015 680+46%
- 2016 1,018+50%
- 2017 1,141+12%
- 2018 1,257+10%
- 2019 1,344+7%
- 2020 1,545+15%
- 2021 1,744+13%
- 2022 1,777+2%
- 2023 1,562-12%
- 2024 1,577+1%
- 2025 1,500-5%
- 2026 1,084-28%
Citing works by country
All citing works in OpenAlex; a paper counts once for each country or institution of its authors.
- United States5,701
- China3,349
- India1,217
- Germany1,204
- United Kingdom1,019
- Japan887
- France611
- South Korea584
- Canada535
- Australia431
- Netherlands424
- Spain346
- Italy337
- Switzerland283
- Denmark270
Citing works by institution
All citing works in OpenAlex; a paper counts once for each country or institution of its authors.
- Chinese Academy of Sciences626
- Harvard University489
- Howard Hughes Medical Institute393
- University of California, Berkeley357
- University of California, San Francisco324
- University of Chinese Academy of Sciences310
- Stanford University292
- Centre National de la Recherche Scientifique276
- State Council of the People's Republic of China272
- Massachusetts Institute of Technology254
- Helmholtz Association of German Research Centres252
- Ministry of Agriculture and Rural Affairs251
- United States Department of Health and Human Services225
- Broad Institute222
- National Institutes of Health214
Research topics of citing works
CRISPR and Genetic Engineering (9,199) · RNA Interference and Gene Delivery (298) · Microbial Metabolic Engineering and Bioproduction (280) · Pluripotent Stem Cells Research (223) · Virus-based gene therapy research (219) · Advanced biosensing and bioanalysis techniques (208) · Biosensors and Analytical Detection (204) · Genetically Modified Organisms Research (157) · Animal Genetics and Reproduction (155) · Genomics and Chromatin Dynamics (117)
Relationships found in this map
- Cites (sentence not available): 51
- Cites as background: 9
Most influential follow-up publications
Ranked by how many other papers in this map cite them, then by total citations. Citation counts measure attention, not validation.
- Le Cong (2013). Multiplex Genome Engineering Using CRISPR/Cas Systems. 15,342 citations; cited by 34 in this map.
- Prashant Mali (2013). RNA-Guided Human Genome Engineering via Cas9. 9,213 citations; cited by 30 in this map.
- Patrick D. Hsu (2013). DNA targeting specificity of RNA-guided Cas9 nucleases. 4,741 citations; cited by 22 in this map.
- Yanfang Fu (2013). High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. 3,294 citations; cited by 17 in this map.
- Martin Jínek (2013). RNA-programmed genome editing in human cells. 2,098 citations; cited by 16 in this map.
Bibliography (APA)
All references were retrieved from OpenAlex on 2 Nov 2026; every entry has a DOI or OpenAlex record.
- Agolinou, A. A. M., Brenas, J., Yemien, S. O. G., Pescod, P., Page, N., Humphreys, H., Lanfrancotti, A., Zongo, N. O., Kaboré, H., Sawadogo, G., Chumbé, S., Diallo, I., et al. (2026). Identification and evaluation of a gRNA targeting the Nudel gene to adapt a gene drive system from Anopheles gambiae to Anopheles funestus for genetic control. https://doi.org/10.12688/verixiv.3174.2
- Knight, A. L., Belato, H. B., Lasekan, P., Dresser, C. S., Pindi, C., Mercado, B. J., Luo, J., Jogl, G., Palermo, G., & Lisi, G. P. (2026). Visualizing the Atomic-Level Impact of Anti-CRISPR II–C1 Inhibition on Geo Cas9 with Integrated Structural Biophysics. JACS Au. https://doi.org/10.1021/jacsau.6c00870
- Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016). Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature. https://doi.org/10.1038/nature17946
- Anzalone, A. V., Randolph, P. B., Davis, J. R., Sousa, A. A., Koblan, L. W., Levy, J. M., Chen, P. J., Wilson, C., Newby, G. A., Raguram, A., & Liu, D. R. (2019). Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. https://doi.org/10.1038/s41586-019-1711-4
- Anzalone, A. V., Koblan, L. W., & Liu, D. R. (2020). Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors. Nature Biotechnology. https://doi.org/10.1038/s41587-020-0561-9
- Chen, B., Gilbert, L. A., Cimini, B. A., Schnitzbauer, J., Zhang, W., Li, G., Park, J. S., Blackburn, E. H., Weissman, J. S., Qi, L. S., & Huang, B. (2013). Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System. Cell. https://doi.org/10.1016/j.cell.2013.12.001
- Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016). High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects. Nature. https://doi.org/10.1038/nature16526
- Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005). Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets. Cell. https://doi.org/10.1016/j.cell.2004.12.035
- Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., OOST, J. v. d., Regev, A., Koonin, E. V., & Zhang, F. (2015). Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System. Cell. https://doi.org/10.1016/j.cell.2015.09.038
- Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012). RNA-guided genetic silencing systems in bacteria and archaea. Nature. https://doi.org/10.1038/nature10886
- Kharismasari, C. Y., Zakiyyah, S. N., Zein, M. I. H., Hardianto, A., Mirasoli, M., Irkham, I., & Hartati, Y. W. (2026). CRISPR/Cas12-powered electrochemical biosensor for chikungunya virus DNA detection using gold-modified screen-printed carbon electrodes. ADMET & DMPK. https://doi.org/10.5599/admet.3564
- Wolbrom, D. H., Matsumura, N., Moroi, M. K., Chauhan, I., Fujiwara, S., Qudus, S., Brewer, M., Ekanayake‐Alper, D. K., Hajosi, D., Schweitzer, L., Takeda, K., Levy, R. J., et al. (2026). Nonischemic and normothermic beating cardiac xenotransplantation. Frontiers in Transplantation. https://doi.org/10.3389/frtra.2026.1984456
- Juszczuk‐Kubiak, E., Piłka, N., Zielińska, E., & Roszko, M. Ł. (2026). CRISPR/Cas in food microbial biotechnology: from genome editing to precision microbiology. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2026.1996037
- Deltcheva, E. M., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011). CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature. https://doi.org/10.1038/nature09886
- Reynolds, E., Farmer, D. L., & Wang, A. (2026). Bioengineering strategies for prenatal therapy. Nature Reviews Bioengineering. https://doi.org/10.1038/s44222-026-00501-y
- Ran, F. A., Hsu, P. D., Wright, J. B., Agarwala, V., Scott, D. A., & Zhang, F. (2013). Genome engineering using the CRISPR-Cas9 system. Nature Protocols. https://doi.org/10.1038/nprot.2013.143
- Ran, F. A., Hsu, P. D., Lin, C., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., & Zhang, F. (2013). Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity. Cell. https://doi.org/10.1016/j.cell.2013.08.021
- Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., Koonin, E. V., Sharp, P. A., et al. (2015). In vivo genome editing using Staphylococcus aureus Cas9. Nature. https://doi.org/10.1038/nature14299
- Mojica, F. J. M., Díez‐Villaseñor, C., García‐Martínez, J., & Almendros, C. (2009). Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology. https://doi.org/10.1099/mic.0.023960-0
- Jiang, F., & Doudna, J. A. (2017). CRISPR–Cas9 Structures and Mechanisms. Annual Review of Biophysics. https://doi.org/10.1146/annurev-biophys-062215-010822
- Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010). Genome editing with engineered zinc finger nucleases. Nature Reviews Genetics. https://doi.org/10.1038/nrg2842
- Hutvágner, G., & Simard, M. J. (2007). Argonaute proteins: key players in RNA silencing. Nature Reviews Molecular Cell Biology. https://doi.org/10.1038/nrm2321
- Wang, H., Yang, H., Shivalila, C., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013). One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering. Cell. https://doi.org/10.1016/j.cell.2013.04.025
- Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014). Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA. Cell. https://doi.org/10.1016/j.cell.2014.02.001
- Deveau, H., Barrangou, R., Garneau, J. E., Labonté, J., Fremaux, C., Boyaval, P., Romero, D. A., Horvath, P., & Moineau, S. (2007). Phage Response to CRISPR-Encoded Resistance in Streptococcus thermophilus. Journal of Bacteriology. https://doi.org/10.1128/jb.01412-07
- Chen, J. S., Ma, E., Harrington, L. B., Costa, M. D., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018). CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. https://doi.org/10.1126/science.aar6245
- Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., Dulay, G. P., Hua, K. L., et al. (2010). A TALE nuclease architecture for efficient genome editing. Nature Biotechnology. https://doi.org/10.1038/nbt.1755
- Sander, J. D., & Joung, J. K. (2014). CRISPR-Cas systems for editing, regulating and targeting genomes. Nature Biotechnology. https://doi.org/10.1038/nbt.2842
- Doudna, J. A., & Charpentier, E. (2014). The new frontier of genome engineering with CRISPR-Cas9. Science. https://doi.org/10.1126/science.1258096
- Du, J., Meng, X., Fan, P., & Si, N. (2026). Precision Gene Therapy for Monogenic Neurological Disorders: Emerging Technologies, Safety, and Mechanism–Modality Matching. Genes. https://doi.org/10.3390/genes17111321
- Doench, J. G., Fusi, N., Sullender, M. E., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I. C. P., Tóthová, Z., Wilen, C. B., Orchard, R. C., Virgin, H. W., Listgarten, J., et al. (2016). Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nature Biotechnology. https://doi.org/10.1038/nbt.3437
- Sambrook, J., Fritsch, E., & Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual. UCLA - Biblioteca de Ciencias de la Salud. openalex.org/W2144634347
- Garneau, J. E., Dupuis, M., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadán, A. H., & Moineau, S. (2010). The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature. https://doi.org/10.1038/nature09523
- Fieder, J., Schneider, S., & Fischer, S. (2026). The historical evolution of CHO cell line development for biologics production: 60 years and still counting. Critical Reviews in Biotechnology. https://doi.org/10.1080/07388551.2026.2738418
- Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., OOST, J. v. d., & Koonin, E. V. (2011). Evolution and classification of the CRISPR–Cas systems. Nature Reviews Microbiology. https://doi.org/10.1038/nrmicro2577
- Makarova, K. S., Wolf, Y. I., Alkhnbashi, O. S., Costa, F., Shah, S. A., Saunders, S. J., Barrangou, R., Brouns, S. J. J., Charpentier, E., Haft, D. H., Horvath, P., Moineau, S., et al. (2015). An updated evolutionary classification of CRISPR–Cas systems. Nature Reviews Microbiology. https://doi.org/10.1038/nrmicro3569
- Darty, K., Denise, A., & Ponty, Y. (2009). VARNA: Interactive drawing and editing of the RNA secondary structure. Bioinformatics. https://doi.org/10.1093/bioinformatics/btp250
- Cong, L., Ran, F. A., Cox, D. B., Lin, S., Barretto, R. P. J., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., & Zhang, F. (2013). Multiplex Genome Engineering Using CRISPR/Cas Systems. Science. https://doi.org/10.1126/science.1231143
- Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013). Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression. Cell. https://doi.org/10.1016/j.cell.2013.02.022
- Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern‐Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., Lim, W. A., Weissman, J. S., et al. (2013). CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes. Cell. https://doi.org/10.1016/j.cell.2013.06.044
- Garbin, M. (2026). ORFan genes and capsid architectures in giant viruses: two structure-guided hypotheses for biomedical innovation. Medical Hypotheses. https://doi.org/10.1016/j.mehy.2026.112218
- Jínek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012). A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity. Science. https://doi.org/10.1126/science.1225829
- Jínek, M., East, A., Cheng, A. T., Lin, S., Ma, E., & Doudna, J. A. (2013). RNA-programmed genome editing in human cells. eLife. https://doi.org/10.7554/elife.00471
- Shuvo, M. N., Ahmed, S., Sarkar., S. S. a. B., Alif, M. I., Hefferon, K. L., & Shohael, A. M. (2026). Integrating Frontier Technologies to Achieve Semi-Dwarfism in Rice: Highlights on Genome Editing and Artificial Intelligence. Crop Breeding Genetics and Genomics. https://doi.org/10.20900/cbgg20260024
- Christian, M. L., Čermák, T., Doyle, E., Schmidt, C. L., Zhang, F., Hummel, A. W., Bogdanove, A. J., & Voytas, D. F. (2010). Targeting DNA Double-Strand Breaks with TAL Effector Nucleases. Genetics. https://doi.org/10.1534/genetics.110.120717
- Abudayyeh, O. O., Gootenberg, J. S., Konermann, S., Joung, J., Slaymaker, I. M., Cox, D. B., Shmakov, S., Makarova, K. S., Semenova, E., Станиславович, М. Л., Severinov, K., Regev, A., et al. (2016). C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science. https://doi.org/10.1126/science.aaf5573
- Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., & Zhang, F. (2013). Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells. Science. https://doi.org/10.1126/science.1247005
- Hsu, P. D., Lander, E. S., & Zhang, F. (2014). Development and Applications of CRISPR-Cas9 for Genome Engineering. Cell. https://doi.org/10.1016/j.cell.2014.05.010
- Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., Cradick, T. J., Marraffini, L. A., et al. (2013). DNA targeting specificity of RNA-guided Cas9 nucleases. Nature Biotechnology. https://doi.org/10.1038/nbt.2647
- Huang, P., Wu, W., Min, Y., Zhang, Y., Tao, Y., Liu, Z., Wei, Z., & Peng, X. (2026). Innovations and emerging trends in adoptive cell therapies for solid tumors: engineering strategies and clinical translation. Experimental Hematology and Oncology. https://doi.org/10.1186/s40164-026-00848-3
- Mali, P., Yang, L., Esvelt, K. M., Aach, J., Güell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013). RNA-Guided Human Genome Engineering via Cas9. Science. https://doi.org/10.1126/science.1232033
- Cheng, Q., Wei, T., Farbiak, L., Johnson, L. T., Dilliard, S. A., & Siegwart, D. J. (2020). Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing. Nature Nanotechnology. https://doi.org/10.1038/s41565-020-0669-6
- Platt, R. J., Chen, S., Zhou, Y., Yim, M., Swiech, L. J., Kempton, H., Dahlman, J. E., Parnas, O., Eisenhaure, T., Jovanović, M., Graham, D. B., Jhunjhunwala, S., et al. (2014). CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling. Cell. https://doi.org/10.1016/j.cell.2014.09.014
- Ruiz, R., Martinez-Martinez, A., Delicado-Mateo, R., Baldanta, S., Montagud‐Martínez, R., & Rodrigo, G. (2026). Computational Design of Prokaryotic Translation Regulation Based on RNA-Binding Proteins. Methods in molecular biology. https://doi.org/10.1007/978-1-0716-5583-2_4
- Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007). CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes. Science. https://doi.org/10.1126/science.1138140
- Du, R., Wang, W., Xie, J., Li, Y., Wu, N., & Xu, Q. C. (2026). Clustered Regularly Interspaced Palindromic Repeats–Cas Genome-Editing Systems in Filamentous Fungi: Current Tools, Optimization Strategies, and Future Perspectives. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.6c12748
- Bae, S., Park, J., & Kim, J. (2014). Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics. https://doi.org/10.1093/bioinformatics/btu048
- Ali, S., Hussian, C. H. A. C., & Goh, H. (2026). Systems biology and synthetic engineering of probiotic yeasts. Biotechnology Advances. https://doi.org/10.1016/j.biotechadv.2026.109084
- Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M. R., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., Aryee, M. J., & Joung, J. K. (2014). GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nature Biotechnology. https://doi.org/10.1038/nbt.3117
- Zhang, S., Yuzhen, H., Zili, Z., Huang, W., Baosheng, Z., & Chan, Y. (2026). Research progress of gene correction for genetic diseases via in vivo prime editing. Molecular Genetics and Genomics. https://doi.org/10.1007/s00438-026-02535-8
- Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Bárcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., Nureki, O., & Zhang, F. (2014). Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature. https://doi.org/10.1038/nature14136
- Xie, S., He, Z., & Yin, H. (2026). Efficient and precise large-scale genomic duplication using amplification editing. Nature Protocols. https://doi.org/10.1038/s41596-026-01454-7
- Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P., Dickman, M. J., Makarova, K. S., Koonin, E. V., & OOST, J. v. d. (2008). Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes. Science. https://doi.org/10.1126/science.1159689
- Roberts, T. C., Langer, R., & Wood, M. J. A. (2020). Advances in oligonucleotide drug delivery. Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-020-0075-7
- Gaj, T., Gersbach, C. A., & Barbas, C. F. (2013). ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. Trends in biotechnology. https://doi.org/10.1016/j.tibtech.2013.04.004
- Leng, T., Lv, Y., Rao, C., Zhu, X., Jiang, Y., Hu, S., Rao, C., & Ma, X. (2026). miR-138-5p: From Multidimensional Tumor-Suppressive Regulatory Networks to Nanocarrier-Based Delivery for Solid Tumor Therapy. DARU Journal of Pharmaceutical Sciences. https://doi.org/10.1007/s40199-026-00683-1
- Tim, W., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2013). Genetic Screens in Human Cells Using the CRISPR-Cas9 System. Science. https://doi.org/10.1126/science.1246981
- Jiang, W., Bikard, D., Cox, D. B., Zhang, F., & Marraffini, L. A. (2013). RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nature Biotechnology. https://doi.org/10.1038/nbt.2508
- Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J. J., & Joung, J. K. (2013). Efficient genome editing in zebrafish using a CRISPR-Cas system. Nature Biotechnology. https://doi.org/10.1038/nbt.2501
- Ma, X., Zhang, Q., Zhu, Q., Liu, W., Chen, Y., Qiu, R., Wang, B., Yang, Z., Li, H., Lin, Y., Xie, Y., Shen, R., et al. (2015). A Robust CRISPR/Cas9 System for Convenient, High-Efficiency Multiplex Genome Editing in Monocot and Dicot Plants. Molecular Plant. https://doi.org/10.1016/j.molp.2015.04.007
- Wang, X., Shi, X., Zheng, X., Ding, Y., Jing, Y., Zhang, J., Wang, J., Li, H., & Zhao, C. (2026). A DNAzyme-activated engineered crRNA enables CRISPR-Cas12a biosensing of ALP and S. aureus. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2026.119360
- Lu, X., Liu, Y., Peng, X., Chen, J., Lu, J., & Zhou, T. (2026). In Vivo Continuous Evolution Systems: Overview, Principles and Applications. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.6c00481
- Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013). High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nature Biotechnology. https://doi.org/10.1038/nbt.2623
- Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014). Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nature Biotechnology. https://doi.org/10.1038/nbt.2808
- Pien, Y., Li, H. z., Bulliard, G., Liu, H., Durbacz, M. Z., Xu, Z., Chai, A. C., Chemello, F., Sanchez‐Ortiz, E., Zabaleta, N., Vandenberghe, L. H., Liu, N., et al. (2026). A single liver-sparing myotropic AAV ameliorates muscular dystrophy in humanized mice by base editing. Journal of Clinical Investigation. https://doi.org/10.1172/jci202378
- Lin, Z., Akin, H., Rao, R., Hie, B., Zhu, Z., Lu, W., Smetanin, N., Verkuil, R., Kabeli, O., Shmueli, Y., Costa, A. d. S., Fazel-Zarandi, M., et al. (2023). Evolutionary-scale prediction of atomic-level protein structure with a language model. Science. https://doi.org/10.1126/science.ade2574